Education
About Us
Working with TipRanks
Follow Us
Santhera Pharmaceuticals Holding Ag (CH:SANN)
:SANN
RESEARCH TOOLSreports
SANN Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SANN Stock 12 Month Forecast
Average Price Target
CHF29.98
▲(145.78%Upside)
| Highest Price TargetCHF29.98 | Average Price TargetCHF29.98 | Lowest Price TargetCHF29.98 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
CHF12
Sell
-1.64%
Downside
Downgraded
06/12/25
H.C. Wainwright
CHF30
Buy
145.90%
Upside
Reiterated
05/27/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
CHF12
Sell
-1.64%
Downside
Downgraded
06/12/25
H.C. Wainwright
CHF30
Buy
145.90%
Upside
Reiterated
05/27/25
Best Analysts Covering Santhera Pharmaceuticals Holding
1 Month
xxx
Success Rate
3/9 ratings generated profit
Average Return
+12.60%
reiterated a xxx
rating 21 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 33.33% of your transactions generating a profit, with an average return of +12.60% per trade.
3 Months
xxx
Success Rate
5/9 ratings generated profit
Average Return
+24.48%
reiterated a xxx
rating 21 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 55.56% of your transactions generating a profit, with an average return of +24.48% per trade.
1 Year
Success Rate
6/9 ratings generated profit
Average Return
+26.53%
reiterated a buy rating 21 days ago
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +26.53% per trade.
2 Years
xxx
Success Rate
9/9 ratings generated profit
Average Return
+47.44%
reiterated a xxx
rating 21 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +47.44% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SANN Analyst Recommendation Trends
Rating
Sep 24
Dec 24
Jan 25
Feb 25
May 25
Strong Buy
5
5
5
4
3
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
5
5
4
3
Each month's total comprises the sum of three months' worth of ratings.
SANN Financial Forecast
SANN Stock Forecast FAQ
What is CH:SANN’s average 12-month price target, according to analysts?
Based on analyst ratings, Santhera Pharmaceuticals Holding Ag’s 12-month average price target is 29.98.
What is CH:SANN’s upside potential, based on the analysts’ average price target?
Santhera Pharmaceuticals Holding Ag has 145.78% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Santhera Pharmaceuticals Holding Ag a Buy, Sell or Hold?
Santhera Pharmaceuticals Holding Ag has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Santhera Pharmaceuticals Holding Ag’s share price target?
The average share price target for Santhera Pharmaceuticals Holding Ag is 29.98. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF29.98 ,and the lowest forecast is CHF29.98. The average share price target represents 145.78% Increase from the current price of CHF12.2.
The highest analyst share price target is CHF29.98 ,and the lowest forecast is CHF29.98. The average share price target represents 145.78% Increase from the current price of CHF12.2.
What do analysts say about Santhera Pharmaceuticals Holding Ag?
Santhera Pharmaceuticals Holding Ag’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of Santhera Pharmaceuticals Holding Ag?
To buy shares of CH:SANN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.